首页> 外文期刊>生物医学与环境科学(英文版) >H5N1 Avian Influenza Pre-pandemic Vaccine Strains in China
【24h】

H5N1 Avian Influenza Pre-pandemic Vaccine Strains in China

机译:中国H5N1禽流感大流行前疫苗株

获取原文
获取原文并翻译 | 示例
       

摘要

ObjectiveTo prepare the 4 candidate vaccine strains of H5N1 avian influenza virus isolated in China. MethodsRecombinant viruses were rescued using reverse genetics. Neuraminidase (NA) and hemagglutinin (HA) segments of the A/Xinjiang/1/2006, A/Guangxi/1/2009, A/Hubei/1/2010, and A/Guangdong/1/2011 viruses were amplified by RT-PCR. Multibasic amino acid cleavage site of HA was removed and ligated into the pCIpolI vector for virus rescue. The recombinant viruses were evaluated by trypsin dependent assays. Their embryonate survival and antigenicity were compared with those of the respective wild-type viruses. ResultsThe 4 recombinant viruses showed similar antigenicity compared with wild-type viruses, chickenembryo survival and trypsin-dependent characteristics. ConclusionThe 4 recombinantviruses rescued using reverse genetics meet the criteria for classification of low pathogenic avian influenza strains, thus supporting the use of them for the development of seeds and production of pre-pandemic vaccines.
机译:目的制备中国分离出的4株H5N1禽流感病毒候选疫苗株。方法采用反向遗传学方法拯救重组病毒。用RT-PCR扩增A /新疆/ 1/2006,A /广西/ 1/2009,A /湖北/ 1/2010和A /广东/ 1/2011病毒的神经氨酸酶(NA)和血凝素(HA)节段PCR。去除HA的多元氨基酸切割位点,并连接到pCIpolI载体中以进行病毒拯救。通过胰蛋白酶依赖性测定法评估重组病毒。将它们的胚胎存活和抗原性与相应的野生型病毒进行比较。结果4种重组病毒与野生型病毒相比具有相似的抗原性,具有鸡胚存活率和胰蛋白酶依赖性。结论通过逆向遗传学挽救的4种重组病毒符合低致病性禽流感病毒株的分类标准,从而支持将其用于种子开发和大流行前疫苗的生产。

著录项

  • 来源
    《生物医学与环境科学(英文版)》 |2014年第10期|763-769|共7页
  • 作者单位

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

    National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention Key Laboratory for Medical Virology, National Health and Family Planning Commission, Beijing 102206, China;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 02:20:22
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号